Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease - Concepedia

Concepedia

Publication | Closed Access

Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease

73

Citations

14

References

2010

Year

Anders Lundin, Espen Dietrichs, Sara Haghighi, Marie-Louise Göller, Arvid Heiberg, Ghada Loutfi, Håkan Widner, Klas Wiktorin, Leif Wiklund, Anders Svenningsson,

Clinical Neuropharmacology

Abstract

Pridopidine shows promise as a treatment for some of the symptoms of HD. In this small-scale study, the most notable effect was improvement in voluntary motor symptoms. Larger, longer-term trials are warranted.

References

	Year	Citations

Page 1